SPY383.63+6.93 1.84%
DIA315.24+5.66 1.83%
IXIC12,920.15+196.68 1.55%

Insider Trends: Insider at Abbott Laboratories Acquires Stock Via Option/Derivative Security Sells Portion to Pay Tax, Buy Trend Intact

· 02/04/2021 14:05

06:58 PM EST, 02/04/2021 (MT Newswires) -- On Feb 02, 2021, Robert E Funck, EVP, exercised options/derivative securities for 31,325 shares of Abbott Laboratories (ABT) and sold 18,241 shares in the company for $2,235,252 to meet tax obligations. After accounting for tax obligations this transaction resulted in a net acquisition of 13,084 company shares. Following the Form 4 filing with the SEC, Funck has control over 213,559 company shares of which 175,301 shares are held directly and 38,258 are controlled indirectly. These holdings have an approximate market value of $25.7 million as of the prior-day closing price.

During the most recent 90-day period, previous to the date of this filing, there have been 12 insider transactions reported to the SEC for Abbott Laboratories. These transactions came from the activities of 7 separate insiders that resulted in a net acquisition of 38,284 company shares. Relative to the preceding 90-day window of time, there were 14 transactions from 8 insiders that resulted in the net acquisition of 13,376 shares.

This is lower than the average level of insider transactions in the 13-company Medical Equipment peer group over the last 90-day period. Within the peer group activity averaged 161.8 transactions per company, and disposition of 6,132 shares on average.

SEC Story Link http://www.sec.gov/Archives/edgar/data/1800/000141588921000535/xslF345X03/form4-02042021_030210.xml

This report does not constitute a recommendation to purchase or sell any security and the analysts are not registered investment advisors. Further analysis is recommended before undertaking any position in any security. Any risks are solely the responsibility of the buyer/seller. The authors, publishers and distributors of the MT Newswires Live Briefs service and any associates thereof accept no liability for the content or actions taken by anyone or institution utilizing this report.